CATALOGO DEI PRODOTTI DELLA RICERCA

CICOIRA, Mariantonietta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.666
EU - Europa 3.339
AS - Asia 915
SA - Sud America 9
OC - Oceania 7
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.943
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.648
GB - Regno Unito 1.617
CN - Cina 648
FR - Francia 304
IE - Irlanda 233
FI - Finlandia 224
RU - Federazione Russa 217
DE - Germania 207
SE - Svezia 203
SG - Singapore 192
IT - Italia 180
UA - Ucraina 97
VN - Vietnam 30
BE - Belgio 15
TR - Turchia 15
CA - Canada 13
IN - India 7
PH - Filippine 7
AU - Australia 6
CZ - Repubblica Ceca 5
JP - Giappone 5
NL - Olanda 5
BR - Brasile 4
IL - Israele 4
IR - Iran 4
CL - Cile 3
DK - Danimarca 3
EG - Egitto 3
MX - Messico 3
PT - Portogallo 3
RO - Romania 3
AT - Austria 2
BG - Bulgaria 2
CH - Svizzera 2
ES - Italia 2
EU - Europa 2
GR - Grecia 2
MD - Moldavia 2
PL - Polonia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
EE - Estonia 1
HK - Hong Kong 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
KG - Kirghizistan 1
KR - Corea 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
ZA - Sudafrica 1
Totale 7.943
Salva come PNG Salva come JPEG
Città #
Southend 1.516
Jacksonville 809
Woodbridge 581
Chandler 509
Ann Arbor 333
Houston 253
Dublin 232
Ashburn 157
Singapore 128
Lawrence 121
Princeton 121
Beijing 120
Wilmington 98
Nanjing 89
Verona 69
Sindelfingen 66
Jinan 62
Boardman 36
Shenyang 34
Hebei 32
Tianjin 27
Changsha 26
Milan 24
Hangzhou 22
New York 22
Dong Ket 20
Helsinki 20
Norwalk 20
Nanchang 19
Taiyuan 18
Zhengzhou 18
Ningbo 16
Brussels 15
Los Angeles 15
Fairfield 14
Taizhou 14
Haikou 13
Jiaxing 13
Guangzhou 12
Düsseldorf 10
Dallas 9
Fuzhou 9
Washington 9
Lancaster 8
Lanzhou 7
Seattle 7
Toronto 7
Auburn Hills 6
Chicago 6
Falls Church 6
Kent 6
Baguio City 5
Orchard Park 5
Redmond 5
Redwood City 5
Riva 5
Bologna 4
Edinburgh 4
London 4
Monza 4
Novokuznetsk 4
Scottsdale 4
Augusta 3
Clearwater 3
Detroit 3
Dongguan 3
Ferrara 3
Lappeenranta 3
Mexico City 3
Moscow 3
Qingdao 3
Ravenna 3
San Diego 3
San Francisco 3
San Mateo 3
Stockholm 3
Tokyo 3
Brescia 2
Cairo 2
Cambridge 2
Canberra 2
Des Moines 2
Montreal 2
Mumbai 2
Olomouc 2
Prague 2
Rio de Janeiro 2
Sabz 2
Santa Clara 2
Sofia 2
St Petersburg 2
Vienna 2
Xiangfen 2
Zanjan 2
Zurich 2
Arbus 1
Athens 1
Auburn 1
Auckland 1
Bergamo 1
Totale 5.939
Salva come PNG Salva come JPEG
Nome #
Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI Score Research Group 661
Cardiorenal Syndrome Type 1: Pathophysiological Crosstalk Leading to Combined Heart and Kidney Dysfunction in the Setting of Acutely Decompensated Heart Failure. 135
Aortic and mitral annular calcification are predictive of all-cause and cardiovascular mortality in patients with type 2 diabetes. 116
Relationship between mitral regurgitation and myocardial viability after acute myocardial infarction: their impact on prognosis 104
Aortic distensibility independently affects exercise tolerance in patients with dilated cardiomyopathy. 100
Skeletal muscle mass independently predicts peak oxygen consumption and ventilatory response during exercise in noncachectic patients with chronic heart failure. 99
Alterazioni muscolari e intolleranza allo sforzo nello scompenso cardiaco congestizio: ruolo centrale della periferia 96
Additional value of pulmonary vein parameters in defining pseudonormalization of mitral inflow pattern. 94
Increased aortic pulse wave velocity as measured by echocardiography is strongly associated with poor prognosis in patients with heart failure. 94
Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circle. 92
High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients. 89
Left atrial overload can be used to estimate mitral regurgitant volume. 88
The role of angiotensin-converting enzyme polymorphism in congestive heart failure. 88
Echocardiographically Derived Pulse Wave Velocity and Diastolic Dysfunction Are Associated with an Increased Incidence of Atrial Fibrillation in Patients with Systolic Heart Failure 87
Aortic stiffness correlates with an increased extracellular matrix turnover in patients with dilated cardiomyopathy. 86
Predicting heart failure outcome from cardiac and comorbid conditions: The 3C-HF score. 86
Role of growth hormone in chronic heart failure: therapeutic implications 85
Chronic heart failure and cardiac cachexia and links between the endocrine and immune system 84
Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. 84
Left Atrial Volume Provides Independent and Incremental Information Compared With Exercise Tolerance Parameters in Patients With Heart Failure and Left Ventricular Systolic Dysfunction. 84
Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure. 83
Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy. 82
Carotid atherosclerotic plaque instability in patients with acute myocardial infarction. 80
Growth hormone resistance in chronic heart failure and its therapeutic implications. 79
Biventricular pacing. 79
ESPEN Guidelines on Enteral Nutrition: Cardiology and pulmonology. 78
Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients 77
Inhibitors of angiotensin-converting enzyme and physical function in older women. 77
Association of deranged adrenal steroid metabolism with anemia in chronic heart failure. 76
Chronic heart failure with preserved left ventricular ejection fraction: Diagnostic and prognostic value of left atrial size. 76
Body mass index, prognosis and mode of death in chronic heart failure: Results from the Valsartan Heart Failure Trial. 76
Growth hormone treatment in chronic heart failure: lessons from the first 99 patients 75
Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia 74
Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients. 74
Aortic distensibility independently affects exercise tolerance in patients with dilated cardiomyopathy 74
Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. 74
Amino-terminal propeptide of type III procollagen is associated with restrictive mitral filling pattern in patients with dilated cardiomyopathy: a possible link between diastolic dysfunction and prognosis. 72
Impact of body mass index on short-term outcome after acute myocardial infarction: does excess body weight have a paradoxical protective role? 72
Echocardiographic determinants of mortality in patients 67 years of age with chronic heart failure 71
Role of growth hormone in chronic heart failure 70
Determinants and prognostic value of left atrial volume in patients with dilated cardiomyopathy. 70
Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype 70
Association of aortic valve sclerosis and coronary artery disease in patients with severe nonischemic mitral regurgitation. 69
Renal arterial pulsatility predicts progression of chronic kidney disease in chronic heart failure patients. 69
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation. 68
Chronic heart failure in the very elderly: clinical status, survival and prognostic factors in 188 patients more than 70 years old 68
Independent and additional prognostic value of aminoterminal propeptide of type III procollagen circulating levels in patients with chronic heart failure. 68
Prognostic implications of evaluation of contractile reserve in akinetic and hypokinetic segments during low dose dobutamine echocardiography in patients with acute myocardial infarction. 68
Functional mitral regurgitation in patients with aortic stenosis: prevalence, clinical correlates and pathophysiological determinants: a quantitative prospective study. 68
Prognostic value of detection of myocardial viability using low-dose dobutamine echocardiography in infarcted patients 67
A higher body mass index is associated with reduced prevalence of unstable atherosclerotic plaque: A possible explanation of the obesity paradox. 67
Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by non-linear analysis: oxygen uptake efficiency slope. 66
Aortic valve sclerosis: a marker of significant obstructive coronary artery disease in patients with chest pain? 66
Identification of High-Risk Chronic Heart Failure Patients in Clinical Practice: Role of Changes in Left Ventricular Function. 66
Uric acid and survival in chronic heart failure: validation and application in metabolic, functional and hemodynamic staging. 65
Beta-blockers can improve survival in medically-treated patients with severe symptomatic aortic stenosis 65
Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration 64
Prediction of mortality in chronic heart failure from peak oxygen consumption adjusted for either body weight or lean tissue. 63
Aortic valve sclerosis is a marker of atherosclerosis independently of traditional clinical risk factors. Analysis in 712 patients without ischemic heart disease. 63
Fill in the Gaps of Secondary Mitral Regurgitation: a Continuum Challenge From Pathophysiology to Prognosis 63
Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not norepinephrine or TNF-alpha 62
Mitral regurgitation and left ventricular diastolic dysfunction similarly affect mitral and pulmonary vein flow Doppler parameters: the advantage of end-diastolic markers. 61
Myocardial viability independently influences left ventricular diastolic function in the early phase after acute myocardial infarction. 60
Effects of ace gene insertion/deletion polymorphism on response to spironolactone in patients with chronic hearth failure. 59
Relation of aldosterone "escape" despite angiotensin-converting enzyme inhibitor administration to impaired exercise capacity in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. 57
Exercise Performance Is a Prognostic Indicator in Elderly Patients With Chronic Heart Failure--Application of Metabolic Exercise Cardiac Kidney Indexes Score 56
Outpatients electrical cardioversion of atrial fibrillation: 8 years' experience. Analysis of shock-related arrhythmias. 55
Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition. 54
Heart failure in women treated with adjuvant trastuzumab fro breast cancer. 54
Prognostic relevance of pulmonary arterial compliance in patients with chronic heart failure. 54
Long-term prognostic value of the stenosis of the infarct-related artery and the presence of viable myocardium in akinetic ventricular regions in infarcted patients 53
Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis 53
Emerging strategies for chronic heart failure: the role of gene therapy 53
Identification of chronic heart failure patients with a high 12-month mortality risk using biomarkers including plasma C-terminal pro-endothelin-1. 52
Aortic stiffness: an old concept for new insights into the pathophysiology of functional mitral regurgitation. 51
Mitral regurgitation, left atrial structural and functional remodelling and the effect on pulmonary haemodynamics 51
Relevance of Functional Mitral Regurgitation in Aortic Valve Stenosis 51
Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow. 50
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias 50
Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group 50
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study 50
Mitral regurgitation and dyspnoea: The expanding role of mitral effective regurgitant orifice among un-selected patients 50
Prognostic relevance of a non-invasive evaluation of right ventricular function and pulmonary artery pressure in patients with chronic heart failure. 49
Ambient air pollution as a new risk factor for cardiovascular diseases: Time to take action 49
Determinants of exercise intolerance symptoms considered non-specific for heart failure in patients with stage A and B: role of the left atrium in the transition phase to overt heart failure 49
Role of iron deficiency and anemia in cardio-renal syndromes. 48
Echocardiographic advances in hypertrophic cardiomyopathy: Three-dimensional and strain imaging echocardiography 48
Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure. 45
Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy. 45
Severe acute left ventricular dysfunction in multiple sclerosis: a case report and review of the literature. 45
Myocardial infarction in a young patient with a previous history of repeated thrombophlebitis: combination of factor V Leiden and prothrombin G20210A gene polymorphisms with coronary artery disease. 45
Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition. 45
Mitral and aortic valve sclerosis/calcification and carotid atherosclerosis: results from 1065 patients. 45
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 45
Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure 44
Obesity paradox in patients with aortic valve stenosis. Protective effect of body mass index independently of age, disease severity, treatment modality and non-cardiac comorbidities. 44
Heart failure and anemia: Effects on prognostic variables 44
null 43
Ischemic etiology of heart failure identifies patients with more severely impaired exercise capacity. 42
Progression of Left Ventricular Dysfunction and Remodelling under Optimal Medical Therapy in CHF Patients: Role of Individual Genetic Background. 42
Totale 7.307
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.655
article - articoli 27.655
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.310
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020949 0 0 19 94 99 120 131 117 49 144 50 126
2020/20211.032 60 176 38 101 123 121 19 95 89 25 130 55
2021/2022723 78 191 18 29 17 28 10 46 23 30 66 187
2022/20231.590 143 119 192 254 156 359 13 119 157 10 46 22
2023/2024659 23 82 58 108 87 71 17 44 3 18 108 40
2024/2025353 150 162 41 0 0 0 0 0 0 0 0 0
Totale 8.062